• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose
incidence increases in parallel with the severity of cirrhosis. Several risk factors have been …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

Background & Aims Liver cirrhosis is complicated by bleeding from portal hypertension but
also by portal vein thrombosis (PVT). PVT occurs in approximately 20% to 50% of patients …

Patients with cirrhosis frequently acquire complex changes in their haemostatic system
including a decreased platelet count and decreased levels of various haemostatic proteins …

Background & Aims Previous meta-analyses demonstrated the safety and efficacy of
anticoagulation in the recanalization of portal vein thrombosis in patients with cirrhosis …

Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the
portal vein, its branches, its radicles, or a combination. This Review first provides a …

Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …